UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 75.00
0.00 (0.00%)
Sep 8, 2026, 1:30 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 4.77 billion as of September 8, 2026. Its market cap has increased by 0.84% in one year.
Market Cap
4.77B
Enterprise Value
4.13B
Revenue
22.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
75.00
ChartMarket Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 4.77B, an increase of 176.21%. That is a compound annual growth rate of 19.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 4.77B | -12.21% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 6.39B |
| Sinphar Pharmaceutical | 6.27B |
| Savior Lifetec | 6.27B |
| Steminent Biotherapeutics | 6.19B |
| Mycenax Biotech | 4.91B |
| Medigen Biotechnology | 4.84B |
| Pharmosa Biopharm | 4.24B |
| Great Novel Therapeutics Biotech & Medicals | 3.88B |